These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15942178)

  • 1. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
    Hara Y; Inoue K; Ogimoto A; Ohtsuka T; Shigematsu Y; Nakata S; Higaki J
    Cardiology; 2005; 104(1):16-21. PubMed ID: 15942178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Nakata S; Shigematsu Y
    Circ J; 2002 Dec; 66(12):1139-43. PubMed ID: 12499621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of beta-blockers on insulin resistance in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Shigematsu Y; Ohtsuka T; Ogimoto A; Higaki J
    Circ J; 2003 Aug; 67(8):701-4. PubMed ID: 12890914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
    Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
    Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Sugioka K; Hozumi T; Takemoto Y; Ehara S; Ogawa K; Iwata S; Oe H; Matsumura Y; Otsuka R; Yoshiyama M; Yoshikawa J
    Am Heart J; 2007 Jun; 153(6):1080.e1-6. PubMed ID: 17540213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
    Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
    J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is myocardial impairment in idiopathic dilated hypertrophic cardiomyopathy reversible by carvedilol?: a case report].
    Ochiai N; Furukawa K; Ebizawa T; Yagi T; Akashi K; Nakamura T; Azuma A; Sugihara H
    J Cardiol; 2000 Sep; 36(3):183-9. PubMed ID: 11022654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy.
    Ito T; Kawanishi Y; Futai R; Terasaki F; Kitaura Y
    Am J Cardiol; 2009 Dec; 104(11):1568-73. PubMed ID: 19932794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between evaluation by quantitative fatty acid myocardial scintigraphy and response to beta-blockade therapy in patients with dilated cardiomyopathy.
    Ito T; Hoshida S; Nishino M; Aoi T; Egami Y; Takeda T; Kawabata M; Tanouchi J; Yamada Y; Kamada T
    Eur J Nucl Med; 2001 Dec; 28(12):1811-6. PubMed ID: 11734920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
    Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
    J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial scintigraphy using iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid predicts the response to beta-blocker therapy in patients with dilated cardiomyopathy but does not reflect therapeutic effect.
    Yoshinaga K; Tahara M; Torii H; Akimoto M; Kihara K; Tei C
    J Cardiol; 2000 May; 35(5):343-51. PubMed ID: 10834178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between the improvement of cardiac function and the myocardial uptake of I-123 metaiodobenzylguanidine in patients with dilated cardiomyopathy treated by beta-blocker].
    Wakita T; Numata Y; Ogata Y; Harada E; Mizumasa Y
    J Cardiol; 1995 Sep; 26(3):177-83. PubMed ID: 7473048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation.
    Zhan DY; Morimoto S; Du CK; Wang YY; Lu QW; Tanaka A; Ide T; Miwa Y; Takahashi-Yanaga F; Sasaguri T
    Cardiovasc Res; 2009 Oct; 84(1):64-71. PubMed ID: 19477965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Slart RH; Tio RA; van der Vleuten PA; Willems TP; Lubbers DD; Dierckx RA; van Veldhuisen DJ
    J Nucl Cardiol; 2010 Jun; 17(3):479-85. PubMed ID: 20238193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment.
    Kawai K; Hata K; Takaoka H; Kawai H; Yokoyama M
    Am Heart J; 2001 Jun; 141(6):925-32. PubMed ID: 11376305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
    Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
    J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
    Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
    Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
    J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.